Reduction of Bedrest Time of Post Percutaneous Renal Biopsy Patients

NCT04629235 | Unknown

• 1 other identifier: 170430
• Study Type: interventional
• Target: 140
• Locations: 1 country
• Sites: 1

Brief Summary

To compare the reduction of the bedrest time of the patient after percutaneous renal biopsy from 24 hours to 8 hours in relation to the occurrence of complications evaluated by the Nursing Outcome Classification (NOC) indicators.

Conditions

Bedrest

Keywords

Renal Biopsy; Complications; Standardized Nursing Terminology

Outcome Measures

Primary Outcomes (1)

• NOC Blood coagulation (0409)

  The primary outcome will be constituted of the absence of bleeding, measured according to the clinical indicators Bleeding (040902), Bruising (040903) and Hematuria (040918). Checked by visual inspection at the puncture location. Check hematuria by visual inspection and test with reagent strips. Evaluated by Likert scale, being 1 the worst score and 5 best score. NOC Blood loss severity (0413): Meansurement of indicators Abdominal distension (041306) and Skin and mucous membrane pallor (041313). Assess the abdominal distension of the patient in the supine position, through inspection and palpation. Assess pallor by inspecting the extremities and mucous membranes, associated with the evaluation of capillary filling with the compression/decompression of the pulp of one or more digits. Evaluated by Likert scale, being 1 the worst score and 5 best score.

  24 hours

Secondary Outcomes (3)

• NOC Circulation status (0401)

  24 hours

• NOC Pain level (2102) as assessed by Visual Analog Pain Scale or Numerical Verbal Pain Scale, asking how much they rate their pain from 0 to 10

  24 hours

• NOC Comfort status: physical (2010)

  24 hours

Study Arms (2)

24 hours of bedrest

ACTIVE COMPARATOR

\- 24 hours of bedrest

Behavioral: bedrest

Intervention group

EXPERIMENTAL

\- Wonder around after 8 hours of bedrest

Other: wonder around

Interventions

wonder around OTHER

wonder around after 8 hours of bedrest

Intervention group

bedrest BEHAVIORAL

24 hours of bedrest

24 hours of bedrest

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• All patients undergoing renal biopsy at Hospital de Clínicas de Porto Alegre (HCPA);
• Both sexes;
• Aged 18 years or older.

You may not qualify if:

• Patients with the following risk factors for complications;
• More than two punctures during the procedure;
• Larger gauge needle;
• Uncontrolled blood pressure;
• Blood clotting disorders and use of antiplatelet agents (aspirin or clopidogrel), or use of anticoagulants;
• Bedridden patients and patients unable to adequately to ambulate.

Sponsors & Collaborators

• Hospital de Clinicas de Porto Alegre: lead

Study Sites (1)

Hospital de Clínicas de Porto Alegre

Porto Alegre, Rio Grande do Sul, 90035-903, Brazil

Location

MeSH Terms

Interventions

Bed Rest

Intervention Hierarchy (Ancestors)

Therapeutics

Study Officials

• Amália de Fátima Lucena

  Hospital de Clínicas de Porto Alegre

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Magáli Costa Oliveira

CONTACT

+5551982378146; magali_oliveirac@hotmail.com

Amália de Fátima Lucena

CONTACT

+5551981794710; afatimalucena@gmail.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: October 30, 2020
• First Posted: November 16, 2020
• Study Start: December 1, 2020
• Primary Completion: December 1, 2021
• Study Completion: June 1, 2022
• Last Updated: November 17, 2020

Record last verified: 2020-11

Data Sharing

• IPD Sharing: Will not share

Locations

BR (1)